应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MAIA MAIA Biotechnology Inc.
交易中 03-16 11:17:41 EDT
1.50
-0.03
-1.96%
最高
1.54
最低
1.48
成交量
16.30万
今开
1.52
昨收
1.53
日振幅
3.76%
总市值
8,799万
流通市值
4,251万
总股本
5,866万
成交额
24.74万
换手率
0.58%
流通股本
2,834万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%
市场透视 · 03-09
Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%
MAIA Biotechnology Inc. 于2026年3月2日与Konik Capital Partners签订承销协议 - 美国证券交易委员会文件
美股速递 · 03-05
MAIA Biotechnology Inc. 于2026年3月2日与Konik Capital Partners签订承销协议 - 美国证券交易委员会文件
MAIA Biotechnology Inc.宣布拟进行普通股及预融资权证的承销公开发行
美股速递 · 03-03
MAIA Biotechnology Inc.宣布拟进行普通股及预融资权证的承销公开发行
Maia Biotechnology, Inc.盘中异动 股价大涨5.08%报1.86美元
市场透视 · 02-13
Maia Biotechnology, Inc.盘中异动 股价大涨5.08%报1.86美元
Maia Biotechnology, Inc.盘中异动 早盘急速上涨5.21%报1.61美元
市场透视 · 01-02
Maia Biotechnology, Inc.盘中异动 早盘急速上涨5.21%报1.61美元
Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.00%报1.26美元
市场透视 · 2025-12-19
Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.00%报1.26美元
Maia Biotechnology, Inc.盘中异动 股价大跌5.28%报1.17美元
市场透视 · 2025-12-18
Maia Biotechnology, Inc.盘中异动 股价大跌5.28%报1.17美元
MAIA Biotechnology宣布在Thio-104三期关键试验中首次为患者使用Ateganosine,作为晚期非小细胞肺癌的三线治疗
美股速递 · 2025-12-11
MAIA Biotechnology宣布在Thio-104三期关键试验中首次为患者使用Ateganosine,作为晚期非小细胞肺癌的三线治疗
Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.16%
市场透视 · 2025-11-26
Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.16%
Maia Biotechnology, Inc.盘中异动 下午盘快速下挫5.00%报1.43美元
市场透视 · 2025-10-29
Maia Biotechnology, Inc.盘中异动 下午盘快速下挫5.00%报1.43美元
Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.59%
市场透视 · 2025-10-27
Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.59%
MAIA Biotechnology公布非小细胞肺癌进行中的II期临床试验30个月患者生存率
美股速递 · 2025-10-23
MAIA Biotechnology公布非小细胞肺癌进行中的II期临床试验30个月患者生存率
Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%报1.28美元
市场透视 · 2025-10-17
Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%报1.28美元
Maia Biotechnology, Inc.盘中异动 早盘快速下挫5.10%
市场透视 · 2025-10-14
Maia Biotechnology, Inc.盘中异动 早盘快速下挫5.10%
Maia Biotechnology, Inc.盘中异动 快速拉升5.10%
市场透视 · 2025-09-27
Maia Biotechnology, Inc.盘中异动 快速拉升5.10%
MAIA Biotechnology Inc. 获得美国国立卫生研究院230万美元资助,用于抗癌药物Thio-101的二期试验
美股速递 · 2025-09-24
MAIA Biotechnology Inc. 获得美国国立卫生研究院230万美元资助,用于抗癌药物Thio-101的二期试验
Maia Biotechnology, Inc.盘中异动 股价大涨5.26%报1.60美元
市场透视 · 2025-09-24
Maia Biotechnology, Inc.盘中异动 股价大涨5.26%报1.60美元
Maia Biotechnology, Inc.盘中异动 股价大涨8.97%报1.70美元
市场透视 · 2025-09-11
Maia Biotechnology, Inc.盘中异动 股价大涨8.97%报1.70美元
MAIA Biotechnology公司公布Thio-101在非小细胞肺癌2期临床试验中的积极疗效数据
美股速递 · 2025-09-11
MAIA Biotechnology公司公布Thio-101在非小细胞肺癌2期临床试验中的积极疗效数据
Maia Biotechnology, Inc.盘中异动 下午盘急速跳水5.36%报1.56美元
市场透视 · 2025-03-11
Maia Biotechnology, Inc.盘中异动 下午盘急速跳水5.36%报1.56美元
加载更多
公司概况
公司名称:
MAIA Biotechnology Inc.
所属市场:
AMEX
上市日期:
--
主营业务:
MAIA Biotechnology, Inc.于2018年8月3日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,开发针对癌症的靶向免疫疗法。该公司的主要资产THIO是一种研究性双重作用机制的候选药物,结合了端粒靶向和免疫原性。THIO是一种端粒靶向剂,目前正在临床开发中以评估其在NSCLC中的活性。THIO正被开发为NSCLC的二线或后续治疗线,用于治疗进展超过现有检查点抑制剂标准治疗方案的患者。公司THIO项目带动了公司第二代端粒靶向剂的开发管线。该公司已经启动了一项早期研究和发现计划,旨在确定能够通过与THIO类似的活性机制发挥作用的新化合物,例如通过癌细胞固有的端粒酶活性靶向和修饰癌细胞的端粒结构。该公司目前的第二代潜在端粒靶向剂管道包括五种化合物,这些化合物已在五种癌症模型中成功进行了体外抑制测试。
发行价格:
--
{"stockData":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.5,"timestamp":1773674254727,"preClose":1.53,"halted":0,"volume":163014,"delay":0,"changeRate":-0.01960784313725492,"floatShares":28340000,"shares":58659600,"eps":-0.768287,"marketStatus":"交易中","change":-0.03,"latestTime":"03-16 11:17:41 EDT","open":1.52,"high":1.54,"low":1.4825,"amount":247399.92504839998,"amplitude":0.037582,"askPrice":1.5,"askSize":360,"bidPrice":1.49,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-0.768287,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773691200000},"marketStatusCode":2,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.53,"preHourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.53,"latestTime":"08:00 EDT","volume":70,"amount":107.10000000000001,"timestamp":1773662407540,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.5295,"preClose":1.53,"latestTime":"19:58 EDT","volume":2512,"amount":3867.472,"timestamp":1773446331265,"change":-0.0005,"changeRate":-0.000327,"amplitude":0.013399},"volumeRatio":0.669196},"requestUrl":"/m/hq/s/MAIA","defaultTab":"news","newsList":[{"id":"2618988226","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618988226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618988226?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:45","pubTimestamp":1773063952,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日21时45分,Maia Biotechnology, Inc.股票出现异动,股价大幅跳水5.19%。截至发稿,该股报1.46美元/股,成交量5.1107万股,换手率0.09%,振幅2.92%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309214552a45bd75d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309214552a45bd75d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"1133621437","title":"MAIA Biotechnology Inc. 于2026年3月2日与Konik Capital Partners签订承销协议 - 美国证券交易委员会文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1133621437","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133621437?lang=zh_cn&edition=full","pubTime":"2026-03-05 06:24","pubTimestamp":1772663051,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件,MAIA Biotechnology Inc. 已于2026年3月2日与Konik Capital Partners正式签署了一项承销协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"1156991089","title":"MAIA Biotechnology Inc.宣布拟进行普通股及预融资权证的承销公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1156991089","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156991089?lang=zh_cn&edition=full","pubTime":"2026-03-03 06:03","pubTimestamp":1772489007,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology Inc.今日宣布,公司计划进行一项承销公开发行,将面向市场发行其普通股及预融资权证。此次融资旨在为公司后续的运营及研发活动提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2611346130","title":"Maia Biotechnology, Inc.盘中异动 股价大涨5.08%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611346130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611346130?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:27","pubTimestamp":1770917248,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日01时27分,Maia Biotechnology, Inc.股票出现波动,股价快速拉升5.08%。截至发稿,该股报1.86美元/股,成交量25.2902万股,换手率0.68%,振幅7.34%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213012729a6f43fc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213012729a6f43fc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2600013567","title":"Maia Biotechnology, Inc.盘中异动 早盘急速上涨5.21%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600013567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600013567?lang=zh_cn&edition=full","pubTime":"2026-01-02 22:42","pubTimestamp":1767364936,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日22时42分,Maia Biotechnology, Inc.股票出现波动,股价急速拉升5.21%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Jasper Therapeutics Inc C/Wts 24/09/2026 、Sellas Life Sciences Group, Inc.、Opus Genetics, Inc.涨幅较大,Sensei Biotherapeutics, Inc.、Can Fite Biopharma Ltd、Outlook Therapeutics, Inc.较为活跃,换手率分别为48.70%、46.20%、30.90%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Genenta Science Spa,振幅分别为38.40%、34.51%、19.46%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010222421697a0f398&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010222421697a0f398&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2592419407","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592419407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592419407?lang=zh_cn&edition=full","pubTime":"2025-12-19 23:16","pubTimestamp":1766157383,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日23时16分,Maia Biotechnology, Inc.股票出现波动,股价大幅上涨5.00%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。其相关个股中,Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、爱美医疗、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃,换手率分别为1560.31%、205.57%、113.02%,振幅较大的相关个股有Geovax Labs, Inc.、Gain Therapeutics, Inc.、Lexaria Bioscience Corp.,振幅分别为57.35%、38.67%、27.56%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219231623a6b7b157&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219231623a6b7b157&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2592218829","title":"Maia Biotechnology, Inc.盘中异动 股价大跌5.28%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592218829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592218829?lang=zh_cn&edition=full","pubTime":"2025-12-18 03:57","pubTimestamp":1766001424,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日03时57分,Maia Biotechnology, Inc.股票出现波动,股价快速跳水5.28%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Processa Pharmaceuticals, Inc.、Vyne Therapeutics Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大,Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Pmgc Holdings Inc.较为活跃,换手率分别为2125.51%、1465.31%、1167.16%,振幅较大的相关个股有Processa Pharmaceuticals, Inc.、健永生技、Protagenic Therapeutics Inc C/Wts 26/04/2026 ,振幅分别为186.35%、84.35%、73.68%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121803570497a06fc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121803570497a06fc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"1151710553","title":"MAIA Biotechnology宣布在Thio-104三期关键试验中首次为患者使用Ateganosine,作为晚期非小细胞肺癌的三线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1151710553","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151710553?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:02","pubTimestamp":1765461732,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology宣布在Thio-104三期关键试验中首次为患者使用Ateganosine,作为晚期非小细胞肺癌的三线治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2586267933","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586267933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586267933?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:11","pubTimestamp":1764169894,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时11分,Maia Biotechnology, Inc.股票出现异动,股价大幅上涨5.16%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Scisparc Ltd.、Pasithea Therapeutics Corp.、Kala Bio, Inc.较为活跃,换手率分别为2436.49%、430.58%、179.75%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 ,振幅分别为272.65%、170.86%、49.76%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231134a7134195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126231134a7134195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","KTTA","BK4139"],"gpt_icon":0},{"id":"2579150809","title":"Maia Biotechnology, Inc.盘中异动 下午盘快速下挫5.00%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579150809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579150809?lang=zh_cn&edition=full","pubTime":"2025-10-29 02:26","pubTimestamp":1761675982,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日02时26分,Maia Biotechnology, Inc.股票出现波动,股价大幅下跌5.00%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Arcutis Biotherapeutics, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大,Aditxt, Inc.、Genprex, Inc.、Bio Green Med Solution, Inc.较为活跃,换手率分别为3673.59%、421.63%、280.31%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ethzilla Corporation C/Wts 06/11/2025、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为87.82%、56.34%、55.06%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102902262397471da2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102902262397471da2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2578935224","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578935224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578935224?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:45","pubTimestamp":1761572709,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日21时45分,Maia Biotechnology, Inc.股票出现异动,股价急速上涨5.59%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.88%。其相关个股中,戴纳基、Avidity Biosciences, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大,Nls Pharmaceutics Ltd.、Cellectar Biosciences, Inc.、Aditxt, Inc.较为活跃,换手率分别为141.50%、117.78%、98.47%,振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、冠科美博、Zenas Biopharma, Inc.,振幅分别为30.20%、19.22%、16.11%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027214509a6d0eb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027214509a6d0eb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"1163990198","title":"MAIA Biotechnology公布非小细胞肺癌进行中的II期临床试验30个月患者生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=1163990198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163990198?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:36","pubTimestamp":1761222983,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology公布非小细胞肺癌进行中的II期临床试验30个月患者生存率","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2576709881","title":"Maia Biotechnology, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576709881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576709881?lang=zh_cn&edition=full","pubTime":"2025-10-17 23:12","pubTimestamp":1760713945,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日23时12分,Maia Biotechnology, Inc.股票出现波动,股价急速跳水5.19%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.47%。其相关个股中,Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Xortx Therapeutics Inc.、Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.较为活跃,换手率分别为1514.46%、479.85%、227.49%,振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Apollomics Inc C/Wts 01/04/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为148.65%、79.83%、61.69%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101723122594cf5cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101723122594cf5cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RANI","BK4539","MAIA","BK4007","BK4139"],"gpt_icon":0},{"id":"2575785678","title":"Maia Biotechnology, Inc.盘中异动 早盘快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575785678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575785678?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:37","pubTimestamp":1760449049,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时37分,Maia Biotechnology, Inc.股票出现波动,股价大幅跳水5.10%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为2001.43%、19.95%、16.98%,振幅较大的相关个股有Genprex, Inc.、Pmgc Holdings Inc.、Osr Holdings, Inc.,振幅分别为25.72%、16.31%、15.67%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101421373094c8d401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101421373094c8d401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2570092850","title":"Maia Biotechnology, Inc.盘中异动 快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570092850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570092850?lang=zh_cn&edition=full","pubTime":"2025-09-27 03:50","pubTimestamp":1758916244,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日03时50分,Maia Biotechnology, Inc.股票出现异动,股价急速上涨5.10%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Applied Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Indaptus Therapeutics, Inc.、Soligenix, Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为1299.57%、150.97%、111.69%,振幅较大的相关个股有Indaptus Therapeutics, Inc.、Applied Therapeutics, Inc.、Yd Bio Ltd C/Wts 28/08/2030,振幅分别为162.20%、134.38%、68.00%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092703504497ac2057&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092703504497ac2057&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"1116579910","title":"MAIA Biotechnology Inc. 获得美国国立卫生研究院230万美元资助,用于抗癌药物Thio-101的二期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1116579910","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116579910?lang=zh_cn&edition=full","pubTime":"2025-09-24 20:01","pubTimestamp":1758715279,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology Inc. 获得美国国立卫生研究院230万美元资助,用于抗癌药物Thio-101的二期试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2569722072","title":"Maia Biotechnology, Inc.盘中异动 股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569722072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569722072?lang=zh_cn&edition=full","pubTime":"2025-09-24 00:12","pubTimestamp":1758643977,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日00时12分,Maia Biotechnology, Inc.股票出现波动,股价快速拉升5.26%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。其相关个股中,Galecto, Inc.、木薯科学、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Galecto, Inc.、Silo Pharma, Inc.、Soligenix, Inc.较为活跃,换手率分别为3676.24%、342.35%、168.97%,振幅较大的相关个股有Adverum Biotechnologies, Inc.、Galecto, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为47.68%、40.33%、38.68%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924001257a69966da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924001257a69966da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139","GLTO"],"gpt_icon":0},{"id":"2566491375","title":"Maia Biotechnology, Inc.盘中异动 股价大涨8.97%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566491375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566491375?lang=zh_cn&edition=full","pubTime":"2025-09-11 21:31","pubTimestamp":1757597489,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日21时31分,Maia Biotechnology, Inc.股票出现波动,股价急速拉升8.97%。截至发稿,该股报1.70美元/股,成交量37.9096万股,换手率1.15%,振幅4.49%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段的生物制药公司,致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911213130a4c11c14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911213130a4c11c14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"1159780980","title":"MAIA Biotechnology公司公布Thio-101在非小细胞肺癌2期临床试验中的积极疗效数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1159780980","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159780980?lang=zh_cn&edition=full","pubTime":"2025-09-11 21:28","pubTimestamp":1757597297,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology公司近日公布了其药物Thio-101在非小细胞肺癌2期临床试验中取得的积极疗效数据,为该公司的癌症治疗研发项目带来重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2518094372","title":"Maia Biotechnology, Inc.盘中异动 下午盘急速跳水5.36%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518094372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518094372?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:31","pubTimestamp":1741631474,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时31分,Maia Biotechnology, Inc.股票出现波动,股价大幅下挫5.36%。截至发稿,该股报1.56美元/股,成交量5.4463万股,换手率0.19%,振幅6.67%。Maia Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为6034.69%、3847.62%、1006.90%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc,振幅分别为90.44%、88.14%、59.34%。Maia Biotechnology, Inc.公司简介:MAIA Biotechnology Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023114a26a935d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023114a26a935d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAIA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maiabiotech.com","stockEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":-0.1356},{"period":"3month","weight":0.125},{"period":"6month","weight":-0.0893},{"period":"1year","weight":-0.0316},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MAIA Biotechnology, Inc.于2018年8月3日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,开发针对癌症的靶向免疫疗法。该公司的主要资产THIO是一种研究性双重作用机制的候选药物,结合了端粒靶向和免疫原性。THIO是一种端粒靶向剂,目前正在临床开发中以评估其在NSCLC中的活性。THIO正被开发为NSCLC的二线或后续治疗线,用于治疗进展超过现有检查点抑制剂标准治疗方案的患者。公司THIO项目带动了公司第二代端粒靶向剂的开发管线。该公司已经启动了一项早期研究和发现计划,旨在确定能够通过与THIO类似的活性机制发挥作用的新化合物,例如通过癌细胞固有的端粒酶活性靶向和修饰癌细胞的端粒结构。该公司目前的第二代潜在端粒靶向剂管道包括五种化合物,这些化合物已在五种癌症模型中成功进行了体外抑制测试。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.285723},{"month":2,"riseRate":0,"avgChangeRate":-0.06082},{"month":3,"riseRate":0.25,"avgChangeRate":-0.012408},{"month":4,"riseRate":0.666667,"avgChangeRate":0.190738},{"month":5,"riseRate":0.666667,"avgChangeRate":0.134126},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.131471},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.058081},{"month":8,"riseRate":0,"avgChangeRate":-0.148704},{"month":9,"riseRate":0.25,"avgChangeRate":0.000086},{"month":10,"riseRate":0.25,"avgChangeRate":-0.039628},{"month":11,"riseRate":0.25,"avgChangeRate":-0.189158},{"month":12,"riseRate":0.5,"avgChangeRate":0.077797}],"exchange":"AMEX","name":"MAIA Biotechnology Inc.","nameEN":"MAIA Biotechnology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MAIA Biotechnology Inc.(MAIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MAIA Biotechnology Inc.(MAIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MAIA Biotechnology Inc.,MAIA,MAIA Biotechnology Inc.股票,MAIA Biotechnology Inc.股票老虎,MAIA Biotechnology Inc.股票老虎国际,MAIA Biotechnology Inc.行情,MAIA Biotechnology Inc.股票行情,MAIA Biotechnology Inc.股价,MAIA Biotechnology Inc.股市,MAIA Biotechnology Inc.股票价格,MAIA Biotechnology Inc.股票交易,MAIA Biotechnology Inc.股票购买,MAIA Biotechnology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MAIA Biotechnology Inc.(MAIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MAIA Biotechnology Inc.(MAIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}